| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genomic Structural Variation | 5 | 2025 | 97 | 1.330 |
Why?
|
| DNA Copy Number Variations | 18 | 2026 | 1029 | 1.170 |
Why?
|
| Alagille Syndrome | 4 | 2019 | 54 | 1.110 |
Why?
|
| Genome, Human | 6 | 2025 | 1321 | 1.080 |
Why?
|
| Human Genetics | 1 | 2025 | 8 | 0.910 |
Why?
|
| Mosaicism | 6 | 2024 | 248 | 0.800 |
Why?
|
| Haplotypes | 2 | 2024 | 519 | 0.790 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2025 | 2833 | 0.780 |
Why?
|
| Polymerase Chain Reaction | 2 | 2024 | 1447 | 0.780 |
Why?
|
| Neurodevelopmental Disorders | 6 | 2024 | 629 | 0.670 |
Why?
|
| Genetic Markers | 3 | 2026 | 587 | 0.670 |
Why?
|
| Chromosome Disorders | 2 | 2025 | 316 | 0.660 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 146 | 0.620 |
Why?
|
| Tetralogy of Fallot | 2 | 2026 | 170 | 0.610 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2026 | 121 | 0.570 |
Why?
|
| Gene Rearrangement | 5 | 2026 | 323 | 0.560 |
Why?
|
| Pedigree | 14 | 2023 | 1677 | 0.560 |
Why?
|
| Gene Duplication | 5 | 2024 | 358 | 0.550 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 325 | 0.540 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2015 | 288 | 0.540 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2024 | 566 | 0.530 |
Why?
|
| Phenotype | 12 | 2026 | 4497 | 0.520 |
Why?
|
| Chromosome Aberrations | 4 | 2026 | 573 | 0.520 |
Why?
|
| Whole Genome Sequencing | 6 | 2026 | 362 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2020 | 3436 | 0.470 |
Why?
|
| Intellectual Disability | 5 | 2023 | 1089 | 0.470 |
Why?
|
| Mutation | 13 | 2022 | 6099 | 0.460 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 36 | 0.450 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1590 | 0.440 |
Why?
|
| Exome | 6 | 2020 | 1061 | 0.430 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 350 | 0.430 |
Why?
|
| Abnormalities, Multiple | 4 | 2026 | 963 | 0.420 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 189 | 0.410 |
Why?
|
| Genetic Association Studies | 6 | 2026 | 819 | 0.410 |
Why?
|
| Genomics | 7 | 2025 | 1621 | 0.400 |
Why?
|
| Jagged-1 Protein | 4 | 2019 | 51 | 0.400 |
Why?
|
| Biliary Atresia | 4 | 2020 | 223 | 0.400 |
Why?
|
| Chromosome Mapping | 3 | 2025 | 1046 | 0.390 |
Why?
|
| Chromosome Inversion | 2 | 2024 | 70 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2024 | 889 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2025 | 109 | 0.360 |
Why?
|
| Software | 3 | 2025 | 733 | 0.340 |
Why?
|
| Humans | 55 | 2026 | 131163 | 0.340 |
Why?
|
| Arthrogryposis | 2 | 2022 | 37 | 0.330 |
Why?
|
| Mutation, Missense | 3 | 2020 | 919 | 0.330 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2024 | 286 | 0.320 |
Why?
|
| Heterozygote | 4 | 2020 | 737 | 0.320 |
Why?
|
| Urogenital Abnormalities | 2 | 2023 | 155 | 0.310 |
Why?
|
| Heterotaxy Syndrome | 2 | 2024 | 61 | 0.300 |
Why?
|
| Chromosome Duplication | 2 | 2021 | 146 | 0.290 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2025 | 468 | 0.290 |
Why?
|
| Microcephaly | 2 | 2023 | 347 | 0.280 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2018 | 52 | 0.270 |
Why?
|
| Receptor, Notch2 | 2 | 2019 | 12 | 0.260 |
Why?
|
| Serrate-Jagged Proteins | 3 | 2015 | 35 | 0.260 |
Why?
|
| Alleles | 4 | 2025 | 1673 | 0.250 |
Why?
|
| Centromere | 1 | 2026 | 67 | 0.240 |
Why?
|
| Chromosomal Instability | 1 | 2026 | 59 | 0.230 |
Why?
|
| Translocation, Genetic | 2 | 2024 | 344 | 0.220 |
Why?
|
| Congenital Abnormalities | 2 | 2026 | 330 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 59 | 0.210 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2024 | 330 | 0.200 |
Why?
|
| Genomic Instability | 2 | 2022 | 245 | 0.200 |
Why?
|
| Male | 27 | 2025 | 64957 | 0.200 |
Why?
|
| Gene Deletion | 2 | 2017 | 767 | 0.200 |
Why?
|
| Rare Diseases | 2 | 2024 | 210 | 0.200 |
Why?
|
| Recombination, Genetic | 1 | 2024 | 422 | 0.190 |
Why?
|
| Genes, Dominant | 2 | 2020 | 242 | 0.190 |
Why?
|
| Female | 27 | 2025 | 70963 | 0.190 |
Why?
|
| Homologous Recombination | 2 | 2020 | 97 | 0.190 |
Why?
|
| Fluorescent Dyes | 1 | 2024 | 246 | 0.190 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 25 | 0.190 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 118 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Contracture | 1 | 2022 | 26 | 0.180 |
Why?
|
| Polydactyly | 1 | 2022 | 18 | 0.180 |
Why?
|
| Apyrase | 1 | 2022 | 23 | 0.180 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.180 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 44 | 0.180 |
Why?
|
| Megalencephaly | 1 | 2022 | 59 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 67 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 248 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 100 | 0.170 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 105 | 0.170 |
Why?
|
| Karyotyping | 2 | 2020 | 308 | 0.170 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 1833 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 526 | 0.160 |
Why?
|
| Alu Elements | 1 | 2021 | 66 | 0.160 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 40 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2020 | 33 | 0.160 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 35 | 0.160 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 63 | 0.160 |
Why?
|
| Symporters | 1 | 2021 | 80 | 0.160 |
Why?
|
| Neoplasms | 1 | 2015 | 3016 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 2020 | 105 | 0.160 |
Why?
|
| Homozygote | 4 | 2024 | 533 | 0.150 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 43 | 0.150 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 47 | 0.150 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2019 | 28 | 0.150 |
Why?
|
| Lissencephaly | 1 | 2019 | 10 | 0.150 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2020 | 82 | 0.150 |
Why?
|
| Dwarfism | 1 | 2020 | 101 | 0.150 |
Why?
|
| White Matter | 1 | 2022 | 219 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 74 | 0.150 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 116 | 0.150 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 118 | 0.150 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 3 | 0.150 |
Why?
|
| Glycine Agents | 1 | 2019 | 10 | 0.150 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 8 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 174 | 0.140 |
Why?
|
| RNA Helicases | 1 | 2019 | 73 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 170 | 0.140 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 251 | 0.140 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1889 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 124 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 123 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 283 | 0.140 |
Why?
|
| Glycine | 1 | 2019 | 156 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 160 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 177 | 0.130 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 176 | 0.130 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 158 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 160 | 0.130 |
Why?
|
| Child | 12 | 2024 | 26341 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2021 | 516 | 0.130 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 775 | 0.130 |
Why?
|
| DNA Repair | 1 | 2020 | 571 | 0.130 |
Why?
|
| Cholesterol | 1 | 2020 | 539 | 0.130 |
Why?
|
| Risperidone | 1 | 2017 | 59 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1075 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2025 | 5063 | 0.120 |
Why?
|
| Infant | 10 | 2021 | 13352 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 743 | 0.120 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8635 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 29 | 0.110 |
Why?
|
| Hypopituitarism | 1 | 2015 | 19 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 81 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 124 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 680 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 149 | 0.110 |
Why?
|
| Siblings | 1 | 2015 | 201 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 378 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2015 | 214 | 0.100 |
Why?
|
| Mitochondria | 1 | 2020 | 785 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2015 | 312 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 375 | 0.100 |
Why?
|
| Hypoxia | 1 | 2015 | 247 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 67 | 0.100 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 65 | 0.100 |
Why?
|
| Chromosome Breakpoints | 2 | 2026 | 81 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2024 | 15110 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2024 | 1692 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1559 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 738 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 132 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 731 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2015 | 385 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 10103 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 327 | 0.090 |
Why?
|
| Placenta | 1 | 2015 | 504 | 0.080 |
Why?
|
| Base Sequence | 1 | 2015 | 2730 | 0.080 |
Why?
|
| Syndrome | 2 | 2025 | 1155 | 0.080 |
Why?
|
| Animals | 7 | 2025 | 33912 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1939 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 363 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2023 | 2406 | 0.070 |
Why?
|
| Adult | 8 | 2021 | 31282 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 934 | 0.070 |
Why?
|
| Adolescent | 6 | 2021 | 20987 | 0.060 |
Why?
|
| Mice | 4 | 2025 | 18301 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 70 | 0.050 |
Why?
|
| Telomere | 1 | 2026 | 219 | 0.050 |
Why?
|
| Liver | 3 | 2018 | 1796 | 0.050 |
Why?
|
| Nodal Protein | 1 | 2024 | 28 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.050 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 15 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 57 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 24 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 208 | 0.050 |
Why?
|
| Mullerian Ducts | 1 | 2023 | 44 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 93 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 10 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Parents | 2 | 2020 | 1128 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 180 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 280 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 88 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2025 | 653 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.050 |
Why?
|
| Consanguinity | 1 | 2022 | 115 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 87 | 0.040 |
Why?
|
| Paraplegia | 1 | 2022 | 84 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 110 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 200 | 0.040 |
Why?
|
| X Chromosome Inactivation | 1 | 2021 | 59 | 0.040 |
Why?
|
| Turkey | 1 | 2021 | 69 | 0.040 |
Why?
|
| Zinc | 1 | 2022 | 128 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 253 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 199 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 155 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 54 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 160 | 0.040 |
Why?
|
| Corneal Opacity | 1 | 2020 | 21 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 64 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2020 | 57 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 23 | 0.040 |
Why?
|
| Digestive System | 1 | 2020 | 58 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 193 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 619 | 0.040 |
Why?
|
| Regenerative Medicine | 1 | 2020 | 39 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 127 | 0.040 |
Why?
|
| Connectin | 1 | 2019 | 30 | 0.040 |
Why?
|
| Tubulin | 1 | 2019 | 76 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2020 | 67 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 588 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2019 | 68 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 134 | 0.040 |
Why?
|
| Axons | 1 | 2022 | 386 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 40 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 127 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 451 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 223 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 141 | 0.040 |
Why?
|
| Retina | 1 | 2022 | 425 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 133 | 0.040 |
Why?
|
| Gastroparesis | 1 | 2020 | 70 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 541 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 194 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 155 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 258 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 729 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 237 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 533 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 2595 | 0.030 |
Why?
|
| Cerebellum | 1 | 2022 | 441 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 138 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 409 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 110 | 0.030 |
Why?
|
| Organogenesis | 1 | 2018 | 75 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 732 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2323 | 0.030 |
Why?
|
| Proteomics | 1 | 2022 | 615 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2019 | 135 | 0.030 |
Why?
|
| Radiography | 1 | 2020 | 743 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 343 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1399 | 0.030 |
Why?
|
| Family | 1 | 2020 | 589 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2020 | 299 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 242 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 317 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 223 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 353 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 555 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 28601 | 0.030 |
Why?
|
| NIMA-Related Kinases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2395 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 876 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3819 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1481 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1626 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 702 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 993 | 0.030 |
Why?
|
| Facies | 1 | 2015 | 157 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 514 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 217 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2701 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 890 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 592 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2013 | 15 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1797 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3359 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 316 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3370 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1928 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 992 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1239 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1979 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1282 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6459 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 7512 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12936 | 0.010 |
Why?
|
| United States | 1 | 2013 | 12072 | 0.010 |
Why?
|